常见肿瘤化疗方案_第1页
常见肿瘤化疗方案_第2页
常见肿瘤化疗方案_第3页
常见肿瘤化疗方案_第4页
常见肿瘤化疗方案_第5页
已阅读5页,还剩97页未读 继续免费阅读

下载本文档

版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领

文档简介

常见肿瘤化疗方案常见肿瘤化疗方案常见肿瘤化疗方案xxx公司常见肿瘤化疗方案文件编号:文件日期:修订次数:第1.0次更改批准审核制定方案设计,管理制度常见肿瘤化疗方案()一、头颈部癌1、DDP+5-FuCisplatin100mg/m2.(1hinf)d15-Fluorouracil1000mg/m2.(continf)d1-4(5)3~4周重复,也可用于放疗前2、CBP+5-FuCarboplatin300mg/m2.d15-Fluorouracil1000mg/m2.(continf)d1-43~4周重复3、IPIfosfamide(异环磷酰胺)1500mg/m2.(Mesna保护)d1-5Cisplatin10mg/m2.(30mininf)d1-54周重复4、TIPPaclitaxel(紫杉醇)175mg/m2.(3hinf)d1Ifosfamide1000mg/m2.(2h,Mesna保护)d1-3Cisplatin60mg/m2.d13~4周重复5、TICPaclitaxel175mg/m2.(3hinf)d1Ifosfamide1000mg/m2.(2h,Mesna保护)d1-3CarboplatinAUC=6.(30mininf)d13~4周重复6、Docetaxel+CisplatinDocetaxel(多西紫杉醇)100mg/m2.(1hinf)d1Cisplatin75mg/m2.(3hinf)d13周重复7、Docetaxel+Cisplatin+5-Fluororacil(TPF)Docetaxel75mg/m2.d1Cisplatin100mg/m2.d15-Fluorouracil1000mg/m2.(continf)d1-43周重复8、PBFCisplatin100mg/m2.(1hinf)d1Bleomycin(博来霉素)15mg.(bolus)d1followedby16mg/m2.(continf)d1-55-Fluorouracil650mg/m2.(continf)d1-54周重复9、BECCisplatin100mg/m2.(1hinf)d1Epirubicin(表柔比星)70mg/m2.(bolus)d1Bleomycin15mg.(bolus)d1followedby12mg/m2.(continf)d1-54周重复二、乳腺癌1、经典CMFCyclophosphamide(环磷酰胺)100mg/m2.d1-14Methotrexate(氨甲喋呤)40mg/m2.d1,85-Fluorouracil600mg/m2.d1,84周重复2、改良CMFCyclophosphamide600mg/m2.d1Methotrexate40mg/m2.d15-Fluorouracil600mg/m2.d13周重复3、ACDoxorubicin(阿霉素(化疗药物))60mg/m2.d1Cyclophosphamide600mg/m2.d1(,8)3周重复4、ECEpirubicin60mg/m2.d1Cyclophosphamide600mg/m2.d13周重复5、IEIfosfamide2000mg/m2.(Mesna保护)d1,8Epirubicin30mg/m2.d1,83周重复6、AC+TDoxorubicin60mg/m2.d1Cyclophosphamide600mg/m2.d13周重复,共4周期,然后Paclitaxel175mg/m2.(3hinf)d13周重复,共4周期7、CAFCyclophosphamide500mg/m2.d1Doxorubicin50mg/m2.d15-Fluorouracil500mg/m2.d13周重复8、CEFCyclophosphamide500mg/m2.d1Epirubicin100mg/m2.d15-Fluorouracil500mg/m2.d13周重复9、Paclitaxel单药Paclitaxel175或200mg/m2.(3hinf)d13周重复10、TADoxorubicin50mg/m2.d1Paclitaxel220mg/m2.(3hinf)d2(ADM后24h)3周重复11、Docetaxel单药Docetaxel75或100mg/m2.(1hinf)d13周重复或者Docetaxel40mg/m2.(1hinf)qw*4/6w3周重复12、Docetaxel+DoxorubicinDoxorubicin50mg/m2.d1Docetaxel75mg/m2.(1hinf)d13周重复13、Vinorelbine+DoxorubicinDoxorubicin40-50mg/m2.d1Vinorelbine20-25mg/m2.d1,83周重复14、Capecitabine单药Capecitabine2510mg/m2.分两次/天,d1-143周重复15、Trastuzumab单药Trastuzumab4mg/kg.(90mininf)负荷量2mg/kg.(30mininf)维持量,qw三、肺癌(一)小细胞肺癌的化疗(SCLC)1、CAOCyclophosphamide1000mg/m2.d1Doxorubicin(阿奇霉素)50mg/m2.d1Vincristine2mg.d13周重复2、CEVCyclophosphamide1000mg/m2.d1Epirubicin70mg/m2.d1Vincristine2mg.d13周重复3、EPCisplatin80mg/m2.(1hinf)d1Etoposide100mg/m2.(2hinf)d1-33周重复4、ECCarboplatin300mg/m2.d1Etoposide120mg/m2.(2hinf)d1-34周重复5、CAECyclophosphamide1000mg/m2.d1Doxorubicin40-50mg/m2.d1Etoposide100-120mg/m2.(1hinf)d1-33周重复6、VIPEtoposide75mg/m2.d1-4Ifosfamide1200mg/m2.(Mesna保护)d1-4Cisplatin20mg/m2.d1-43周重复7、Topotecan单药Topotecanm2.(30mininf)d1-53周重复8、Paclitaxel+CarboplatinPaclitaxel175mg/m2.(3hinf)d1CarboplatinAUC=7.(30mininf)d13周重复(二)非小细胞肺癌的化疗(NSCLC)1、Docetaxel单药Docetaxel75mg/m2.(1hinf)d13周重复2、Gemcitabine单药Gemcitabine1000-1250mg/m2.(30mininf)d1,8,154周重复3、Vinorelbine单药Vinorelbine30mg/m2.(20mininf)d1,8,154周重复4、NPVinorelbine25mg/m2.d1,8,15Cisplatin100mg/m2.d14周重复5、Paclitaxel+CisplatinPaclitaxel175mg/m2.(3hinf)d1Cisplatin80mg/m2.(1hinf)d13周重复6、Paclitaxel+CarboplatinPaclitaxel225mg/m2.(3hinf)d1CarboplatinAUC=6.d13周重复7、Docetaxel+CisplatinDocetaxel75mg/m2.d1Cisplatin75mg/m2.d13周重复8、Gemcitabine+CisplatinGemcitabine1000mg/m2.(30-60mininf)d1,8,15Cisplatin100mg/m2.(30-60mininf)d14周重复9、EPCisplatin100mg/m2.(30-60mininf)d1Etoposide100mg/m2.(2hinf)d1-33周重复四、食管癌1、DDP+5-FuCisplatin100mg/m2.(2hinf)d15-Fluorouracil1000mg/m2.(continf)d1-53~4周重复2、Paclitaxel+CisptatinPaclitaxel180mg/m2.(3hinf)d1Cisplatin60mg/m2.(3hinf)d13周重复3、TPEPaclitaxel50mg/m2.(1hinf)d1,4Cisplatin15mg/m2.(1hinf)d1,4Etoposide50mg/m2.(continf)d1,4QW*3,休息1周,4周一疗程4、ECFEpirubicin50mg/m2.d1Cisplatin60mg/m2.d15-Fluorouracil200mg/m2.(continf)d1-213周重复五、胃癌1、5-Fu+CF+DDPCisplatin50mg/m2.(1hinf)biwFolinicacid500mg/m2.(2hinf)qw*65-Fluorouracil2000mg/m2.(24hinf)qw*62、ECFEpirubicin50mg/m2.d1Cisplatin60mg/m2.d15-Fluorouracil200mg/m2.(continf)d1-213周重复3、FAMTXMethotrexate1~1.5g/m2.d15-Fluorouracil1500mg/m2.d1Doxorubicin30mg/m2.d15Folinicacid15mg/m2.MTX后24h,q6h*124周重复4、ELFEtoposide120mg/m2.(50mininf)d1-3Folinicacid300mg/m2.(10mininf)d1-35-Fluorouracil500mg/m2.(10mininf)d1-33~4周重复5、TCDocetaxel85mg/m2.(1hinf)d1Cisplatin75mg/m2.(1hinf)d13周重复六、大肠癌1、MayoClinicFolinicacid20mg/m2.(bolus)d1-55-Fluorouracil425mg/m2.(bolus)d1-54周重复2、deGramontFolinicacid200mg/m2.(2hinf)d1-25-Fluorouracil400mg/m2.(bolus)d1-2600mg/m2.(22hinf)d1-22周重复3、IrinotecanMonotherapyIrinotecan125mg/m2.(90mininf)qw*46周重复或者Irinotecan300-350mg/m2.(90mininf)d13周重复4、FOLFORIIrinotecan125mg/m2.(90mininf)qw*4Folinicacid20mg/m2.(bolus)qw*45-Fluorouracil500mg/m2.(bolus)qw*46周重复或者Irinotecan180mg/m2.(90mininf)d1Folinicacid200mg/m2.(2hinf)d1-25-Fluorouracil400mg/m2.(bolus)d1-2600mg/m2.(22hinf)d1-22周重复5、Irinotecan+OxaliplatinIrinotecan200mg/m2.(30mininf)d1Oxaliplatin85mg/m2.(2hinf)d13周重复6、OxaliplatinMonotherapyOxaliplatin130mg/m2.(2hinf)d13周重复7、FOLFOX4Oxaliplatin85mg/m2.(2hinf)d1Folinicacid200mg/m2.(2hinf)d1-25-Fluorouracil400mg/m2.(bolus)d1-2600mg/m2.(22hinf)d1-22周重复8、FOLFOX6Oxaliplatin100mg/m2.(2hinf)d1Folinicacid400mg/m2.(2hinf)d15-Fluorouracil400mg/m2.(bolus)d1-22400~3000mg/m2.(46hinf)d1-22周重复9、RaltitrexedRaltitrexed3mg/m2.d13周重复10、CapecitabineCapecitabine1250mg/m2.bid*143周重复11、UFT+CFUFT100mg/m2.tid*28Folinicacid30mg/m2.tid*285周重复七、胰腺癌1、GemcitabineGemcitabine1000mg/m2.(30mininf)qw*7;休息1周后每周1次,连用3周,4周一疗程2、5-Fluorouracil5-Fluorouracil500mg/m2.(bolus)d1-54周重复3、CF+5-FuFolinicacid20mg/m2.(2hinf)d1-55-Fluorouracil425mg/m2.(bolus)d1-54周重复4、Gemcitabine+CF+5-FuGemcitabine1000mg/m2.(30mininf)d1,8,15,22Folinicacid200mg/m2.(2hinf)d1,8,15,225-Fluorouracil750mg/m2.(continf)d1,8,15,226周重复八、胆管癌1、5-Fluorouracil5-Fluorouracil500mg/m2.d1-54周重复或者5-Fluorouracil600mg/m2.d1,8,154周重复2、GemcitabineGemcitabine1000mg/m2.(30mininf)d1,8,154周重复3、GemcitabineGemcitabine2200mg/m2.(30mininf)d12周重复4、DocetaxelDocetaxel100mg/m2.(1hinf)d13周重复5、FLMFolinicacid200mg/m2.d1-45-Fluorouracil400mg/m2.d1-4Mitomycin8mg/m2.d14周重复6、5-Fu+IFN-a5-Fluorouracil750mg/m2.(continf)d1-5Interferonalpha5*106IU.d1,3,52周重复九、宫颈癌1、IPIfosfamide5000mg/m2.(24hinf,Mesna保护)d1Cisplatin50mg/m2.d13周重复2、ICIfosfamide5000mg/m2.(24hinf,Mesna保护)d1Carboplatin300mg/m2.d14周重复3、BIPBleomycin30mg/m2.(24hinf)d1Ifosfamide5000mg/m2.(24hinf,Mesna保护)d2Cisplatin50mg/m2.d24周重复4、TIPPaclitaxel175mg/m2.(3hinf)d1Ifosfamide5000mg/m2.(24hinf,Mesna保护)d2Cisplatin50mg/m2.d24周重复5、TPPaclitaxel135mg/m2.(24hinf)d1Cisplatin50~75mg/m2.d23周重复6、PFCisplatin75mg/m2.d15-Fluorouracil1000mg/m2.(continf)d1-43周重复,也可同时合并放疗十、子宫内膜癌1、APDoxorubicin60mg/m2.d1Cisplatin50~60mg/m2.d13周重复2、TCPaclitaxel175mg/m2.(3hinf)d1CarboplatinAUC=5~7.(30mininf)d13周重复3、PCDDoxorubicin45mg/m2.d1Paclitaxel160mg/m2.(3hinf)d1Cisplatin60mg/m2.(1hinf)d13周重复,G-CSF支持十一、卵巢癌一线化疗1、TPPaclitaxel135mg/m2.(3h或24hinf)d1Cisplatin75mg/m2.(1mg/min)d1或d23周重复2、TCPaclitaxel175mg/m2.(3hinf)d1CarboplatinAUC=5~6.(1hinf)d13周重复3、CBP+CTXCyclophosphamide600mg/m2.d1Carboplatin300mg/m2.(1hinf)d14周重复挽救治疗1、TopotecanTopotecan~m2.(30mininf)d1-53周重复2、EtoposideEtoposide50~100mg/m2.d1-143周重复3、GemcitabineGemcitabine800~1250mg/m2.(30mininf)d1,8,154周重复4、IfosfamideIfosfamide1200~2400mg/m2.(30min~2hinf,Mesna保护)d1-53~4周重复或者Ifosfamide1000mg/m2.(coninf,Mesna保护)d1-74周重复5、IPIfosfamide1500mg/m2.(1hinf,Mesna保护)d2-5Paclitaxel175mg/m2.(3hinf)d13周重复6、IMIfosfamide2000mg/m2.(30mininf,Mesna保护)d1-3Mitoxantrone10mg/m2.(30mininf)d13~4周重复7、脂质体ADM脂质体ADM50mg/m2.(1hinf)d14周重复十二、绒毛膜癌低危1、MethorexateMethorexate~kg.或.(bolus)d1-5周重复2、DactinomycinDactinomycin10~12ug/kg.(bolus)d1-5周重复高危1、EMA-COEtoposide100mg/m2.(1hinf)d1-2Methorexate100mg/m2.d1200mg/m2.(12hinf)d1Dactinomycinm2.(bolus)d1-2Cyclophosphamide600mg/m2.(30mininf)d8Vincristinem2.(bolus)d83周重复2、MACMethorexatekg.d1-5Dactinomycin8~10ug/kg.(bolus)d1-5Cyclophosphamide250mg.(bolus)d1-5Chlorambucilkg.d1-52~3周重复3周重复3、挽救治疗低危1、EAEtoposide100mg/m2.(1hinf)d1-3Dactinomycinm2.(bolus)d1-310天重复高危1、EP/EMAEPEtoposide150mg/m2.(30mininf)d1Cisplatin75mg/m2.(4hinf)d1EMAEtoposide100mg/m2.(30mininf)d1Methorexate300mg/m2.(12hinf)d1Dactinomycin.(bolus)d1Folinicacid15mgbid,.或.(MTX后24h,q6h*4)d2,3EP/EMA每周交替十三、生殖细胞恶性肿瘤(一)非精原细胞瘤1、BEPBleomycin30mg/m2.(bolus)d1,8,15Etoposide100mg/m2.(1hinf)d1-5或165mg/m2.(1hinf)d1-3Cisplatin50mg/m2.d1-2或20mg/m2.d1-53周重复2、ACEDactinomycin.(bolus)d1-3Cyclophosphamide500mg/m2.(30mininf)d3Etoposide100mg/m2.(1hinf)d1-34周重复3、VIPEtoposide200mg/m2.(1hinf)d1-5Ifosfamide1600mg/m2.(1hinf,Mesna保护)d1-5Cisplatin30mg/m2.(1hinf)d1-53周重复,G-CSF支持4、T-BEPPaclitaxel175mg/m2.(1hinf)d1Bleomycin30mg.(bolus)d1,8,15Etoposide200mg/m2.(1hinf)d1-5Cisplatin30mg/m2.(1hinf)d1-53周重复,G-CSF支持5、VeIPVinblastinekg.(bolus)d1-2Ifosfamide1200mg/m2.(1hinf,Mesna保护)d1~5Cisplatin20mg/m2.(30mininf)d1~53周重复6、TIPPaclitaxel250mg/m2.(24hinf)d1Ifosfamide1200mg/m2.(1hinf,Mesna保护)d2-6Cisplatin20mg/m2.(30mininf)d2-63周重复,G-CSF支持(二)精原细胞瘤EP1、BEPEtoposide100mg/m2.(1hinf)d1-5Cisplatin20mg/m2.(30mininf)d1-53周重复2、VeIPVinblastinekg.(bolus)d1-2Ifosfamide1200mg/m2.(1hinf,Mesna保护)d1~5Cisplatin20mg/m2.(30mininf)d1~53周重复十四、原发不明转移瘤1、TCEPaclitaxel200mg/m2.(1hinf)d1CarboplatinAUC=6.(20~30mininf)d1Etoposide50mg.d1,3,5,7,9100mg.d2,4,6,8,103周重复2、PEBBleomycin30mg.(bolus)d1,8,15Etoposide100mg/m2.(1hinf)d1-5Cisplatin20mg/m2.d1~53周重复3、DCDocetaxel65mg/m2.d1CarboplatinAUC=6.d13周重复4、TFLPaclitaxel175mg/m2.(3hinf)d1Folinicacid300mg.(30~60mininf)d1-35-Fluorouracil350mg/m2.(30~60mininf)d1-34周重复5、VACVinblastinem2.d1Doxorubicin50mg/m2.d1Cyclophosphamide500mg/m2.d13周重复十五、恶性黑色素瘤1、DacarbazineDacarbazine850~1000mg/m2.d1或者250mg/m2.d1-53~4周重复2、FotemustineFotemustine100mg/m2.(1hinf)d1,8,153周重复3、VindesineVinblastine3mg/m2.d12周重复,共1年;然后3周重复,共6月;最后4周重复,共6月4、低剂量IFNInterferonalpha3MU月5、中剂量IFNInterferonalpha10MU天/周4周;然后5MU年6、高剂量IFNInterferonalpha20MU/m2.或5天/周4周;然后10MU/m2周7、Interleukin-2Interleukin-2600000或720000IU/kg.(15min)每8小时一次,共14次,2周重复;若耐受,6~12周为一疗程,最多5疗程8、Dartmouth方案Cisplatin25mg/m2.(30~45mininf)d1-3BCNU150mg/m2.(shortinf)d1Dacarbazine220mg/m2.(shortinf)d1-3Tamoxifen20~40mg.化疗前1周开始3周重复9、DVPDacarbazine250mg/m2.(30mininf)d1-5Vindesine3mg/m2.(bolus)d1,8,15Cisplatin100mg/m2.(30mininf)d14周重复10、Dacarbazine+InterferonalphaDacarbazine800mg/m2.(shortinf)d1Interferonalpha9MU周重复11、Dacarbazine+Cisplatin+Interferonalpha+Interleukin-2Dacarbazine250mg/m2.(30mininf)d1-3Cisplatin25mg/m2.(1hinf)d1-3Interferonalpha5MU/m2.d6,8,10,13,15Interleukin-218MU/m2.(15mininf)d6-10,13-154周重复十六、恶性间皮瘤1、EpirubicinEpirubicin110mg/m2.(bolus)d13周重复2、VinorelbineVinorelbine30mg/m2.(5mininf)qw6周为一疗程3、APDoxorubicin60mg/m2.(bolus)d1Cisplatin60mg/m2.(1hinf)d13~4周重复4、GPGemcitabine1000mg/m2.(30mininf)d1,8,15Cisplatin100mg/m2.(2hinf)d14周重复十七、神经内分泌癌1、DoxorubicinDoxorubicin60mg/m2.(bolus)d13~4周重复2、5-Fluorouracil5-Fluorouracil500mg/m2.(bolus)d1-55周重复3、EPEtoposide130mg/m2.(24hinf)d1-3Cisplatin45mg/m2.(24hinf)d2-34周重复4、CVDCyclophosphamide750mg/m2.(bolus)d1Vincristinem2.(bolus)d1Dacarbazine600mg/m2.(bolus)d13~4周重复5、EAPDoxorubicin20mg/m2.(bolus)d1,8Etoposide100mg/m2.(1hinf)d5-7Cisplatin40mg/m2.(1hinf)d2,94周重复4、EDF5-Fluorouracil500mg/m2.d1-3Dacarbazine200mg/m2.(30mininf)d1Etoposide30mg/m2.d1-33周重复十八、软组织肉瘤1、IAIfosfamide5000mg/m2.(24hinf,Mesna保护)d1Doxorubicin50~75mg/m2.(shortinf)d13周重复或者Ifosfamide2000mg/m2.(24hinf,Mesna保护)d1-5Doxorubicin25mg/m2.(continf)d1-33周重复2、IEIfosfamide1800mg/m2.(1hinf,Mesna保护)d1-5Epirubicin60mg/m2.(shortinf)d1-23周重复3、MAIDIfosfamide2000~2500mg/m2/d.(continf,Mesna保护)d1-3Doxorubicin15mg/m2/d.(continf)d1-4Dacarbazine250mg/m2/d.(continf)d1-43周重复4、IVAIfosfamide3000mg/m2.(Mesna保护)d1-2Dactinomycinm2(max2mg).d1Vincristinem2(max2mg).d1,8,153~4周重复5、APDoxorubicin60mg/m2.d1Cisplatin100mg/m2.d13~4周重复十九、胸腺瘤1、CAPCyclophosphamide500mg/m2.(bolus)d1Doxorubicin50mg/m2.(bolus)d1Cisplatin50mg/m2.(1hinf)d13周重复2、ADOCCyclophosphamide700mg/m2.(bolus)d4Doxorubicin40mg/m2.(bolus)d1Cisplatin50mg/m2.(1hinf)d1Vincristinem2.(bolus)d23周重复3、EPEtoposide120mg/m2.(30mininf)d1-3Cisplatin60mg/m2.(1hinf)d13周重复4、IfosfamideIfosfamide1500mg/m2.(30mininf,Mesna保护)d1-55、BEPBleomycin30mg/m2.(bolus)d1,8,15Etoposide100mg/m2.(1hinf)d1-5Cisplatin50mg/m2.d1-23周重复二十、膀胱癌1、MVACMethotrexate30mg/m2.(bolus)d1,15,22Vinblastine3mg/m2.(bolus)d1,15,22Doxorubicin30mg/m2.(bolus)d1Cisplatin70mg/m2.(1~2hinf)d24~5周重复2、GPGemcitabine1000mg/m2.(30~60mininf)d1,8,15Cisplatin70mg/m2.(60mininf)d24周重复3、Paclitaxel+CisplatinPaclitaxel175mg/m2.(3hinf)d1Cisplatin75mg/m2.(1hinf)d13周重复4、CMVMethotrexate30mg/m2.(bolus)d1,8Vinblastine4mg/m2.(bolus)d1,8Cisplatin70~100mg/m2.(1hinf)d23周重复5、ITPPaclitaxel200mg/m2.(3hinf)d1Cisplatin70mg/m2.(1hinf)d1Ifosfamide1500mg/m2.(1hinf,Mesna保护)d1-33~4周重复,G-CSF支持二十一、多发性骨髓瘤1、MPMelphalankg/d.d1-4Prednisone100mg/d.d1-44周重复2、M2Vincristinem2.d1BCNU20mg/m2.d1Melphalan8mg/m2.d1-4Cyclophosphamide400mg/m2.d1Prednisone100mg/d.d1-45周重复3、Thalidomide+DexamethasoneThalidomide200mg/d.d1-28Dexamethasone40mg/d.d1-4,9-12,17-203周重复二十二、恶性淋巴瘤(一)霍奇金淋巴瘤1、MOPPNitrogenmustard6mg/m2.d1Vincristinem2(max2mg).d1Procarbazine100mg/m2.d1-14Prednisone40mg/m2.d1-144周重复2、ABVDDoxorubicin25mg/m2.d1,15Bleomycin10mg/m2.d1,15Vinblastine6mg/m2.d1,15Dacarbazine375mg/m2.d1,154周重复3、ChlVPPCB13486mg/m2.d1-14Vinblastine6mg/m2.d1,8Procarbazine100mg/m2.d1-14Prednisone40mg/m2.d1-144周重复4、B-CAVEBleomycin5mg/m2.d1,8,15CCNU100mg/m2.d1Doxorubicin60mg/m2.d1Vinblastine5mg/m2.d14周重复5、CVBBleomycin15mg/m2.d1,8CCNU100mg/m2.d1Vinblastine6mg/m2.d1,84周重复挽救方案1、EVAEtoposide100mg/m2.d1-3Doxorubicin50mg/m2.d1Vinblastine6mg/m2.d14周重复2、BEAMBCNU60mg/m2.(30mininf)d1Etoposide75mg/m2.d2-5Cytarabine100mg/m2bid,.(30mininf)d2-5Melphalan30mg/m2.d64周重复3、ASHAPDoxorubicin10mg/m2.(continf)d1-4Cisplatin25mg/m2.(continf)d1-4Cytarabine1500mg/m2.(2hinf)d5Methylprednisolone500mg/m2.(15mininf)d1-54周重复(二)非霍奇金淋巴瘤1、COPPCyclophosphamide650mg/m2.d1,8Vincristinem2(max2mg).d1,8Procarbazine100mg/m2.d1-14Prednisone40mg/m2.d1-144周重复2、COMPCyclophosphamide400mg/m2.d1,8Vincristinem2(max2mg).d1,8Methetrexate25mg/m2.d1,8Prednisone30mg/m2.d1-144周重复3、CHOPCyclophosphamide750mg/m2.d1Vinc

温馨提示

  • 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
  • 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
  • 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
  • 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
  • 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
  • 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
  • 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

评论

0/150

提交评论